Growth rate of export was 20% in KOSDAQ, but negative in KOSPI
While pharmaceutical companies in the KOSDAQ showed a large growth in overseas sales & export on average compared to the year before, KOSPI listed pharmaceutical companies recorded a negative value in the growth ratio. The KOSDAQ listed pharmaceutical companies’ ratio of overseas sales & exports ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.